Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Breast cancer symbols : ONCY save search
Oncolytics Biotech® and SOLTI Present New Clinical Biomarker Data Demonstrating Pelareorep's Potential to Improve the Prognosis of Breast Cancer Patients at the ESMO Breast Cancer Meeting
Published: 2022-05-04 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.16%
H: 2.11%
C: 0.7%
biotech potential cancer breast cancer biomarkers
Oncolytics Biotech® and SOLTI Announce Upcoming Poster Presentation at the European Society for Medical Oncology Breast Cancer Meeting
Published: 2022-05-02 (Crawled : 12:20) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 6.06%
C: 5.3%
biotech presentation cancer breast cancer
Oncolytics Biotech® Partner Adlai Nortye Advances Chinese Bridging Trial of Pelareorep-Paclitaxel Combination Treatment in Breast Cancer to Final Dosing Cohort
Published: 2022-03-24 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.63%
H: 4.43%
C: 3.8%
biotech chinese treatment trial cancer breast cancer
Oncolytics Biotech® Partner Adlai Nortye Advances to the Second Dose Escalation Cohort of the Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer
Published: 2022-01-27 (Crawled : 12:30) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.73%
H: 0.0%
C: -5.85%
biotech chinese treatment trial cancer iot breast cancer
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.21%
H: 0.98%
C: 0.98%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
treatment cancer breast cancer merge
Big Trend Occurring in Triple-Negative Breast Cancer Treatment Is The Shift Towards Combination Therapy
Published: 2021-12-10 (Crawled : 14:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -6.7%
H: 0.0%
C: 0.0%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: -4.78%
H: 0.0%
C: 0.0%
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: -1.42%
H: 0.0%
C: 0.0%
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -13.0%
H: 0.0%
C: 0.0%
treatment therapy cancer negative breast cancer
Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium
Published: 2021-12-10 (Crawled : 12:30) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -6.7%
H: 0.0%
C: 0.0%
biotech phase 2 symposium trial positive cancer negative iot breast cancer
Oncolytics Biotech® to Present Phase 2 Triple-Negative Breast Cancer Trial Update at the 2021 San Antonio Breast Cancer Symposium
Published: 2021-11-19 (Crawled : 14:30) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -2.29%
H: 3.51%
C: 1.75%
biotech phase 2 cancer iot breast cancer trial symposium
Oncolytics Biotech®Partner Adlai Nortye Doses First Patient in Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer
Published: 2021-10-14 (Crawled : 12:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.42%
H: 3.26%
C: 1.86%
chinese treatment cancer biotech iot breast cancer trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.